Ensign Peak Advisors, Inc Neogenomics Inc Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 51,740 shares of NEO stock, worth $284,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,740
Previous 51,740
-0.0%
Holding current value
$284,052
Previous $852,000
42.37%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NEO
# of Institutions
280Shares Held
126MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$108 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$78.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$36.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$33.2 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$31.5 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $691M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...